Yasuhiko Deguchi Selected Research

nervonic acid

1/2021	Nervonic acid level in cerebrospinal fluid is a candidate biomarker for depressive and manic symptoms: A pilot study.
1/2018	Plasma Nervonic Acid Is a Potential Biomarker for Major Depressive Disorder: A Pilot Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuhiko Deguchi Research Topics

Disease

5	Bipolar Disorder (Manic Depressive Psychosis) 01/2022 - 02/2017
3	Major Depressive Disorder (Major Depressive Disorders) 01/2021 - 01/2018
3	Schizophrenia (Dementia Praecox) 01/2018 - 02/2017
2	Inflammation (Inflammations) 01/2022 - 01/2018
1	Parkinsonian Disorders (Parkinsonism) 01/2022
1	Psychomotor Agitation (Akathisia) 01/2022
1	Vomiting 01/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022
1	Nausea 01/2022
1	Neoplasms (Cancer) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Mania (Manias) 01/2021
1	Occupational Stress 03/2020
1	Mood Disorders (Mood Disorder) 01/2018

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 01/2022 - 02/2017
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 02/2017
2	Mitochondrial DNA (mtDNA)IBA 01/2022 - 01/2018
2	nervonic acidIBA 01/2021 - 01/2018
1	Quetiapine Fumarate (Seroquel)FDA Link 01/2022
1	Olanzapine (Zyprexa)FDA Link 01/2022
1	Biperiden (Akineton)FDA Link 01/2022
1	Clonazepam (Rivotril)FDA LinkGeneric 01/2022
1	Antipsychotic Agents (Antipsychotics)IBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2022
1	Metoclopramide (Reglan)FDA LinkGeneric 01/2022
1	hydroxide ionIBA 03/2020
1	CytokinesIBA 01/2018
1	Betaine (C.B.B.)FDA Link 02/2017

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2022
1	Polypharmacy 01/2022